Form 8-K - Current report:
SEC Accession No. 0001193125-24-237865
Filing Date
2024-10-16
Accepted
2024-10-16 08:21:00
Documents
18
Period of Report
2024-10-16
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d869403d8k.htm   iXBRL 8-K 41681
2 EX-3.1 d869403dex31.htm EX-3.1 7485
3 EX-10.1 d869403dex101.htm EX-10.1 94047
4 EX-10.2 d869403dex102.htm EX-10.2 59049
5 EX-99.1 d869403dex991.htm EX-99.1 10843
6 EX-99.2 d869403dex992.htm EX-99.2 8458
  Complete submission text file 0001193125-24-237865.txt   402839

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA me-20241016.xsd EX-101.SCH 2846
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20241016_lab.xml EX-101.LAB 17982
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20241016_pre.xml EX-101.PRE 11258
21 EXTRACTED XBRL INSTANCE DOCUMENT d869403d8k_htm.xml XML 3749
Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 241373345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)